The preclinical application of 3D tissue models has now grown to include toxicology, disease modeling and precision medicine. With this development comes the need to clarify, validate and reproduce these advantages to continue to drive preclinical success in drug development and disease modeling.
The PREDiCT 4th Annual 3D Tissue Models Summit is the only meeting to bring together 120+ industry stakeholders across the regulatory, pharma, biotech and academic landscapes for effective cross-talk between world leading experts.
Join us and discover:
- 20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress.
- FDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users.
- NIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology.
- Model developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types.
Take advantage of this unrivaled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.
Find out what's new in the 2019 edition of the 3D Tissue Models Summit!